Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low dose IV contrast in CKD patients
NCT02476526Phase 4Completed
- Sponsor
- VA Greater Los Angeles Healthcare System
- Start
- Sep 2008
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iodixanol in pulmonary embolism (PE), renal artery stenosis (RAS), lung cancer, Acute aortic syndrome (AAS), sponsored by VA Greater Los Angeles Healthcare System. Started Sep 2008; status: completed.
02
Drugs
iodixanol
03
Conditions
pulmonary embolism (PE)renal artery stenosis (RAS)lung cancerAcute aortic syndrome (AAS)
Beyond the preview
Go deeper on NCT02476526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476526.